Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $671,232 - $797,778
13,800 New
13,800 $797,000
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $879,350 - $969,650
21,500 Added 42.41%
72,200 $3.2 Million
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $1.23 Million - $1.44 Million
32,200 Added 174.05%
50,700 $2.15 Million
Q1 2021

May 17, 2021

SELL
$35.27 - $39.67 $15.6 Million - $17.6 Million
-443,300 Reduced 95.99%
18,500 $715,000
Q4 2020

Feb 16, 2021

BUY
$33.15 - $41.97 $13.9 Million - $17.6 Million
418,900 Added 976.46%
461,800 $16.6 Million
Q2 2020

Aug 14, 2020

BUY
$30.19 - $39.11 $646,066 - $836,954
21,400 Added 99.53%
42,900 $1.51 Million
Q1 2020

May 15, 2020

BUY
$25.83 - $45.71 $555,345 - $982,765
21,500 New
21,500 $701,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $125B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.